Corriente Advisors, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 23 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Corriente Advisors, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$906,000
-88.6%
203,641
-76.6%
0.49%
-83.3%
Q1 2021$7,963,000
-2.7%
870,228
+7.8%
2.93%
+50.5%
Q4 2020$8,182,000
+164.4%
806,900
+10.5%
1.95%
+24.2%
Q3 2020$3,095,000
+121.9%
730,000
+262.7%
1.57%
+73.6%
Q2 2020$1,395,000201,2480.90%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 500,000$1,420,0003.26%
Altium Capital Management LP 287,698$817,0620.56%
Bleichroeder LP 222,317$631,3800.14%
COOPERMAN LEON G 1,767,246$5,018,9780.12%
Aristides Capital LLC 106,333$301,9860.11%
CATALYST FINANCIAL PARTNERS LLC 36,267$102,9980.03%
Naples Money Management LLC 3,878$11,0140.01%
Stonebridge Capital Advisors LLC 20,000$56,8000.01%
Legend Financial Advisors, Inc. 1,000$2,8400.00%
FIRST MANHATTAN CO. LLC. 114,744$325,8720.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders